Patients Rising Now joined 50 other organizations in a letter to President Biden requesting that he direct HHS Secretary Becerra to reopen the National Coverage Determination (NCD) on PET scans for patients participating in Alzheimer’s treatments trials. CMS’ current policy is ‘one scan per lifetime’ which hampers critical initiatives taking place in the Alzheimer’s research space. This policy does not align with what medical professionals may call for in an Alzheimer’s research trial or care regimen, and it’s long overdue for change. Updating the decades old policy would allow for real breakthroughs that would bring about major improvements in the lives of Alzheimer’s and related dementias patients’ lives. Patients Rising Now fully supports expanding coverage for additional scans and encourages everyone to read the letter.